This is the first study, to our knowledge, performed on a significant number of strains (79 carbapenem-resistant Enterobacteriaceae and 84 carbapenem-resistant non-fermenting Gramnegative rods, GNRs) isolated from tissue samples taken from patients in the intensive care units of two large hospitals in Bucharest, Romania, between 2011 and 2012. The results revealed a high prevalence and great diversity of carbapenemase genes (CRG), in both fermenting and non-fermenting Gram-negative carbapenem-resistant strains. The molecular screening of carbapenem-resistant GNRs revealed the presence of worldwide-distributed CRGs (i.e. bla and bla NDM-1 in Enterobacteriaceae and bla , bla , bla OXA-10-like , bla OXA-60-like , bla SPM-like and bla GES-like in non-fermenting GNRs), reflecting the rapid evolution and spread of carbapenemase producers, particularly in hospitals. Rapid identification of the colonized or infected patients is required, as are epidemiological investigations to establish the local or imported origin of the respective strains.
INTRODUCTION
Carbapenemases represent the most versatile family of blactamases, with a breadth of spectrum unrivalled by other b-lactam-hydrolysing enzymes (Queenan & Bush, 2007) . Although known as carbapenemases, many of these enzymes recognize almost all hydrolysable b-lactams, and most are resilient against inhibition by all commercially available b-lactamase inhibitors ; this resilience is often accompanied by resistance to other classes of antibiotics. Carbapenem-resistant Enterobacteriaceae represent a cause of difficult-to-treat infections in hospitalized patients associated with high mortality, and these strains have also been spreading in long-term care facilities (CDC, 2013; Perez & Van Duin, 2013; Tzouvelekis et al., 2012) . Although most carbapenem resistance in Pseudomonas aeruginosa is due to porin loss, hospital outbreaks of metallo-blactamase-producing P. aeruginosa have occurred worldwide 3These authors contributed equally to this work.
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On: Wed, 12 Dec 2018 12:20:54 (Livermore, 2012) . Carbapenem-resistant Acinetobacter baumannii strains are increasingly isolated and pose a significant threat to hospitalized patients as the therapeutic options are scarce (Pogue et al., 2013) , while some other nonfermenting Gram-negative bacilli emerging in nosocomial infections, such as Stenotrophomonas maltophilia, are constitutively producing carbapenemases (Mercuri et al., 2002) .
The actual prevalence of carbapenemase producers is still unknown because many countries that are likely to be the main reservoirs have not yet implemented standardized protocols for their detection. It is estimated that we are on the edge of a worldwide carbapenemase-producer epidemic, which in the hospital environment is likely to be caused mainly by nosocomial carbapenemase-producers of all types (e.g. Klebsiella pneumoniae strains producing KPC, IMP, VIM, NDM and OXA-48 enzymes) . This is the first study, to our knowledge, performed on a significant number of strains to establish the prevalence of the different carbapenemase genes (CRGs) in fermenting and non-fermenting Gram-negative bacilli isolated from hospitalized patients in the intensive care units (ICUs) of two large hospitals in Bucharest, the capital city of Romania, as previous studies have described the prevalence of carbapenemases in other parts of the country (Bonnin et al., 2011; Székely et al., 2013) .
METHODS
Carbapenem-resistant strains identified in tissue samples.
Using clinical samples collected from patients hospitalized in the ICUs of two large hospitals in Bucharest, Romania, between 2011 and 2012, 347 carbapenem-resistant Gram-negative rod (GNR) strains (143 Enterobacteriaceae and 204 non-fermenting GNR) were consecutively selected based on resistance phenotypes to more than two classes of b-lactam antibiotics. Since 1999, the two hospitals, encoded CCI and SCF in our study, have been included in the European Antimicrobial Resistance Surveillance System. The identification of the strains and the quantitative antibiotic susceptibility assays were performed by the Vitek II (bioMérieux) and MicroScan (Siemens Healthcare) automatic systems.
Disc diffusion tests for resistance phenotypes. The resistance phenotypes of the Enterobacteriaceae strains were established using: disc diffusion tests with amoxicillin+clavulanic acid (Amc), amikacin (Amk), aztreonam (Atm), ceftazidime (Caz), chloramphenicol (Chl), ciprofloxacin (Cip), colistin (Col), cefotaxime (Ctx), cefuroxime (Cxm), ertapenem (Etp), cefepime (Fep), cefoxitin (Fox), gentamicin (Gen), imipenem (Imp), levofloxacin (Lvx), meropenem (Mem), minocycline (Min), nitrofurantoin (Nit), norfloxacin (Nor), trimethoprim+sulfamethoxazole (Sxt), tetracycline (Tet) and tobramycin (Tob) according to CLSI guidelines and tigecycline (Tgc) according to the European Committee on Antimicrobial Susceptibility Testing guidelines (www.eucast.org/clinical-breakpoints); double-disc diffusion tests with Amc plus EDTA, and Imp and Imp plus EDTA; the Modified Hodge Test; and E-tests for extended-spectrum b-lactamases (ESBLs), MBL and AmpC. Resistance to Col was assessed by broth microdilution, according to CLSI guidelines.
The resistance phenotypes for non-fermenting GNRs were established for A. baumannii using disc diffusion tests with piperacillin (Pip), ceftriaxone (Cro), piperacillin-tazobactam (Tzp), Fep, Imp, Caz, Cip, Tet, Sxt, Gen and Amk. For S. maltophilia disc diffusion tests with Sxt, Chl, ticarcillin (Tic), ticarcillin+clavulanic acid (Tic+clav), Lvx, Min and Caz were used; and for P. aeruginosa Tzp, Atm, piperacillin (Prl), Chl, Imp, Fep, Gen and Cip were used, according to CLSI guidelines. The carbapenem resistance phenotypes were confirmed by E-tests for ESBL, MBL and AmpC.
PCR to determine the genetic basis of the resistance. The genetic support of the b-lactam resistance mediated by enzymic mechanisms was investigated by PCR for all strains exhibiting a carbapenemase-producing phenotype, using a reaction mix of 20 or 25 ml (PCR Master Mix 26, Thermo Scientific) containing 1 ml of thermal-lysed bacterial cell suspension. The following CRG primers were used: bla NDM , bla KPC , bla VIM , bla IMP , bla SPM , bla AIM , bla SIM , bla DIM , bla GIM , bla BIC, bla OXA-2, bla OXA-10 , bla OXA-23 , bla OXA-24 , bla OXA-48 , bla OXA-50 , bla OXA-55 , bla OXA-60 , bla OXA-69 and bla GES (Table 1 ). Amplification for screening was carried out using GoTaq Green Master Mix (Promega) and the following thermal cycling protocol: 10 min at 94 uC and 36 cycles of amplification consisting of 30 s at 94 uC, 40 s at 52 uC and 50 s at 72 uC, with 5 min at 72 uC for the final extension step.
Sequencing of the class I integron, bla NDM-1 , bla OXA-23 and bla . PCR reaction products were sequenced using Premix Taq DNA Polymerase (TaKaRa Taq, Takara Bio) with the following conditions: 94 uC for 5 min, followed by 30 cycles at 94 uC for 30 s, 50 uC for the class 1 integron, 52 uC for OXA-48, 55 uC for NDM and OXA-23, then 72 uC for 1.5 min, except for class 1 integron, with an elongation step at 72 uC for 5 min. The final elongation was at 72 uC for 10 min. PCR products were separated in 1.5 % agarose gels for 1 h at 80 V, stained with ethidium bromide and detected by UV transillumination. The amplicons were sequenced using an ABI 3730xl DNA Analyser with a 10 s annealing time at 55 uC (Applied Biosystems) and the sequences were analysed using ChromasLite 2.1.1 (http://www.technelysium.com.au). Sequencing primers are given in Table 2 . Sequencing was carried out at the Beijing Genomics Institute (Beijing, China).
RESULTS AND DISCUSSION
This study focussed on screening the CRGs circulating in Romania. This is the first study to our knowledge performed on a significant number of strains isolated during a one year survey between 2011 and 2012 in two major hospitals in Bucharest, the capital and most populated city of Romania. Due to a major influx of people from all over the country, this study aimed to establish the prevalence of CRGs in southern Romania, as similar studies have already been performed for Enterobacteriaceae in northern Romania (Székely et al., 2013) and for non-fermenting GNRs in the west (Bonnin et al., 2011) . These studies described the presence of bla OXA-48 , bla NDM-1 and bla OXA-181 in Enterobacteriaceae strains isolated in northern Romania, bla in A. baumannii in west Romania, and bla VIM-2 in P. aeruginosa in north-east Romania (Mereuta et al., 2013) .
We selected two large hospitals in Bucharest, with a total of 2445 beds and a catchment population of 2 500 000, representing a national coverage of 12.5 %; we considered this a significant percentage of the southern Romanian population. In the survey performed between October 2011 and November 2012, 79 carbapenem-resistant Enterobacteriaceae and 84 carbapenem-resistant non-fermenting The phenotypic analysis revealed a very high percentage of carbapenem resistance, among the analysed strains of both Enterobacteriaceae (35 %) and non-fermenting GNR (41.1 %) (data not shown).
Enterobacteriaceae strains
For the 143 Enterobacteriaceae strains, 98 were K. pneumoniae, 24 Enterobacter cloacae, 11 Klebsiella oxytoca and 10 Escherichia coli. Of these, 50 strains were identified as carbapenemase-producing Enterobacteriaceae, based on the Hodge test results (Table 3 ) and the IMP/IMP+EDTA tests (data not shown). The carbapenemase-producing Enterobacteriaceae encountered in the two hospital ICUs were K. pneumoniae (39 strains), Enterobacter cloacae (10 strains) and Escherichia coli (1 strain). All carbapenemaseproducing Enterobacteriaceae strains were multidrug-resistant, based on the Vitek and MicroScan file reports, and 80 % (n540) concomitantly exhibited other b-lactaminactivating enzymes, such as AmpC (18 %, n59) and ESBL (62 %, n531), based on the disc diffusion tests.
The Enterobacteriaceae strains exhibiting carbapenem resistance phenotypes, and the two K. pneumoniae strains susceptible to Imp, harboured bla OXA-48 (31 strains) and bla NDM-1 (19 strains) (Fig. 1, Table 3 ), results which confirm the establishment of these two carbapenemase genes in southern Romania. bla OXA-48 is the most frequent carbapenemase in Germany, seen occasionally in patients with connections to Turkey. NDM was discovered in 2008 and, due to its rapid worldwide dissemination and ability to be expressed by numerous Gram-negative pathogens, is assumed will become the most commonly isolated and distributed carbapenemase worldwide (Marsik & Nambiar, 2011; Patel & Bonomo, 2013) , rendering the identification of producer strains extremely important. NDM producing strains may carry a high number of other resistance genes (CRGs of OXA-48 and VIM types, plasmid-mediated cephalosporinase genes, ESBL genes, aminoglycoside resistance genes -16S RNA methylases, macrolide resistance genes -esterases, rifampicin modifying enzymes and sulfamethoxazole resistance genes), therefore becoming a source of multidrug and pandrug resistance .
The bla OXA-48 and bla NDM-1 genes have already been reported in northern Romania. Northern Romania is mostly inhabited by a Hungarian minority who have strong connections with Hungary; however, in Hungary (Grundmann et al., 2010) as we found in our screening.
Non-fermenting GNR strains
Of the 204 non-fermenting GNR strains isolated from the clinical specimens, 124 were P. aeruginosa, 49 A. baumannii, 17 S. maltophilia, four A. baumannii/haemolyticus, three Empedobacter brevis and two Acinetobacter lwoffii.
The phenotypic analysis of antibiotic resistance revealed that 33.8 % (n542) of P. aeruginosa strains were multidrug-resistant, 16.9 % (n521) were extensively drug resistant, and 20.9 % (n526) revealed a MBL phenotype (Table 4) . Of A. baumannii strains, 63.2 % (n531) were extensively drug-resistant strains.
In our study, the most frequent genes detected in carbapenem-resistant non-fermenting GNR strains were bla OXA-23 , bla GES-like and bla VIM-4 . The majority of the CRGs were detected in P. aeruginosa and A. baumannii strains (Fig. 2) .
Carbapenemase resistance genes
Some clinical isolates of P. aeruginosa strains harboured the CRG bla VIM-4 . To our knowledge this is the first report of bla VIM-4 in Romania. The bla VIM-4 type was identified using the RHR and RHS primers for the class I integron described in Table 2 , the amplicon obtained being sequenced using the Sanger method at the Beijing Genome Institute. VIM-4 is a single amino-acid variant of the VIM-1-b-lactamases, first described in P. aeruginosa strains isolated in Greece in 2001 (Pournaras et al., 2002) , thereafter identified in Sweden in the same year (2001), and subsequently identified as the most common integronencoded MBL in Enterobacteriaceae species in several European countries (Sardelic et al., 2012) . Of the VIM-type carbapenemases, bla VIM-2 has previously been described in P. aeruginosa clinical isolates from north-east Romania (Mereuta et al., 2013) . This suggests an unequal distribution of VIM-type enzymes in Romania, probably due to the geographical proximity of south Romania with Greece.
Of the oxacillinases (OXA) and ESBLs with carbapenemase activity (GES), the most common metallo-b-lactamase families identified in the analysed non-fermenting GNRs include the VIM, IMP, GIM and the more recently described NDM-1-type enzymes (Girlich et al., 2004; Lauretti et al., 1999; Peleg et al., 2004; Poirel et al., 2000; Yong et al., 2006) .
For naturally occurring carbapenemases, including bla OXA-50 (data not shown), the analysed non-fermenting GNR strains exhibited bla OXA-10 , bla OXA-23 and bla . Out of these oxacillinases, bla OXA-23 was the most frequent among the tested strains, being present as the single CRG or in association with other CRGs, such as bla OXA-10 , GES, VIM and SPM. The alarming spread of OXA-23 carbapenemase in Acinetobacter sp. strains has been recently signalled in other parts of the world, including Egypt (Fouad et al., 2013) , North India (Niranjan et al., 2013) and Turkey (Cicek et al., 2013) . 
Carbapenem-resistant bacilli in Romanian ICUs
Production of ESBLs of the GES type in A. baumannii has been increasingly reported in isolates from Middle East countries, Palestinian territories, Turkey and Egypt, and some of these GES-type enzymes possess some carbapenemase activity (Bogaerts et al., 2010) . In our strains, GES-type genes were the most frequent in Pseudomonadaceae strains.
The Sao Paulo metallo-b-lactamase (SPM) was first isolated in a P. aeruginosa strain in Sao Paolo, Brazil, and since then, single clones of SPM-1-producing P. aeruginosa have caused multiple hospital outbreaks with high mortality in Brazil (Marra et al., 2006; Poirel et al., 2004; Zavascki et al., 2005) . This gene was also detected in strains isolated from Iran (Shahcheraghi et al., 2011) and Spain (Villaló n et al., 2013).
The CRG profiles in the non-fermenting GNR strains proved to be more diverse than those detected in the Enterobacteriaceae strains. Some of the genes analysed were found in both hospital units: bla OXA-23 , bla GES-like , bla VIM-4 , while others were detected only in strains isolated from SCF (bla OXA-10 , bla OXA-60 , bla SPM ). In the CCI unit, the most frequent association was represented by bla GES-like +bla VIM-4 found in P. aeruginosa (n54), while in the SCF hospital unit, the most frequent association was bla OXA-23 +bla OXA-10-like in A. baumannii (n53). The strains isolated from the CCI hospital showed a larger spectrum of CRGs that could be explained by the fact that this institution receives patients with underlying cardiovascular disease from all over the country meaning that the distribution observed here could be relevant to the national distribution of CRGs.
Some of the CRGs identified in south Romania have a worldwide distribution, such as bla OXA-48 and bla NDM-1 in
Enterobacteriaceae and bla OXA-23 , bla VIM-4 , bla OXA-10 in non-fermenting GNRs, while others are reported to be endemic in certain countries or geographical areas (e.g. bla SPM in non-fermenting GNRs in Brazil) (Silva et al., 2011) .
CONCLUSIONS
This first study to our knowledge performed on a significant number of strains reported a high prevalence and wide diversity of carbapenemase genes in fermenting and non-fermenting Gram-negative strains isolated from patients hospitalized in the ICUs of hospitals in south Romania. The molecular screening of carbapenem-resistant GNRs revealed the presence of worldwide-distributed genes, reflecting the spread of carbapenemase producers, particularly in hospitals. Rapid identification of colonized or infected patients is needed, as are epidemiological investigations to establish the local or imported origin of the respective strains. 
